Price: 35.06

Today's Change: -0.09

Today's Percent Change: -0.39%

Today's Volume: 23523848

Average Daily Volume: 17232100

52 week low: 29.83

52 week high: 36.78

Market cap: 208510000000.0

EBITDA: 20240000000.0

EBITDA / market_cap: 9.71%

Earnings per Share (EPS): 1.37

EPS / price: 3.91%

Dividend Yield: 3.6%

Dividend per share: 1.28

Book value: 9.81

Price to Book Ratio: 3.58

Price to Earnings (P/E) Ratio: 25.65

Price to Earnings Growth (PEG) Ratio: 2.28

Price to Sales (P/S) Ratio: 3.99

Short Ratio: 2.37

Exchange: "NYQ"

Short term: UP (Previous: UP)

Mid term: UP (Previous: UP)

Long term: UP (Previous: UP)

Support: 32.88

Resistance: 33.17

Pivot point: 33.01

SMA 10: 33.20

SMA 50: 33.67

SMA 100: 32.90

RSI 10: 29.17

RSI 50: 49.91

RSI 100: 51.43

EMA 10: 33.26

EMA 50: 33.75

EMA 100: 32.70

STRONG BUY

Based on 12 buy signals and 0 sell signals

Previous signal: strong buy

32.10

NEGATIVE

PFE
PFE

@JohnCendpts: Laiisez les bon temps rouler -- Pfizer lines up a potential $687M rare disease buyout to expand its stake in the ho… https://t.co/YIr20CW2hO

@TheBurdetteLawF: #estate asset watch - max money flow Wed. (price x shares traded) $AMZN $AAPL $AMD $NFLX $BA $NVDA $DIS $FB $BABA… https://t.co/87NxqJyYwe

@FlyOnTheWallHQ: RT @FlyOnTheWallHQ: A Game Of Two Halves_IOVANCE BIOTHERAPEUTICS $IOVA To Be Scooped Up In All Cash Transaction By Pfizer $PFE, Announcemen…

@FlyOnTheWallHQ: RT @FlyOnTheWallHQ: A Fool And His Money Are Soon Parted_LEXICON PHARMACEUTICALS $LXRX To Be Scooped Up In Cash And Stock Transaction By Pf…

@WealthMDs: RT @GantosJ: $PFE deal with Vivet $51M upfront & up to $635M for full B/O, show how good & ahead of the crowd $SRPT was, when they signed a…

@WealthMDs: RT @MauriceOnTW: That didn't take long (if $PFE exercises option)! Maybe 1/3 right $PFE pays 51M upfront for 15% and up to 635.8M for Vive…

@WealthMDs: RT @jeff_cranmer: $PFE deal w/France's Vivet is at least its 5th disclosed #genetherapy deal in past 3 years. Pfizer has option to buy afte…

@WealthMDs: RT @MauriceOnTW: Here is the $PFE PR https://t.co/tpGn7lle5Y Joining $RARE, others? in Wilson disease #GeneTherapy The company was on my…

@newswithvalue: $CSCO $PFE: 5 of the Best Dow Jones Stocks to Buy for Solid Dividends: https://t.co/49vap8ENfl

@TheBurdetteLawF: #estate asset watch - most active stocks Wednesday - $AMD $BAC $ACB $F $GE $NIO $CZR $ECA $MTFB $SIRI $MU $AAPL… https://t.co/kiP9Bl5qLL

@mr_ericryan: RT @IQStockAlerts1: Upcoming catalysts make $QBIO an attractive biotech play for many reasons. Take a look at the chart! $CRLBF $EMHTF $I…

@newswithvalue: $AGN $XPH $PFE: Allergan Stock Won’t Benefit From a Breakup, Analyst Says: https://t.co/C7PYkQtuLQ

@aaaamhim: $GETH U CANT IGNORE THESE HUGE BUYS! About to pop💸🍾 #ico $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX… https://t.co/VtuJQspuSJ

@biologypartners: RT @jeff_cranmer: $PFE deal w/France's Vivet is at least its 5th disclosed #genetherapy deal in past 3 years. Pfizer has option to buy afte…

@MauriceOnTW: RT @jeff_cranmer: $PFE deal w/France's Vivet is at least its 5th disclosed #genetherapy deal in past 3 years. Pfizer has option to buy afte…